Search Within

David G Pfister

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (25)
  2. Meeting Abstract (18)
  3. Research Letter (2)
  4. Editorial (1)
Groups
  1. Department of Medicine (46)
  2. Head and Neck Service (46)
  3. Population Sciences Research Program (46)
  4. Solid Tumor Oncology Division (46)
  5. Epidemiology and Biostatistics (30)
  6. Survivorship Research (28)

More Groups

People
  1. Eric Sherman (16)
  2. Nancy Lee (16)
  3. Matthew Fury (15)
  4. Ronglai Shen (14)
  5. Jatin Shah (12)
  6. Sofia Haque (11)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (3)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Cancer (5)
  3. International Journal of Radiation Oncology, Biology, Physics (4)
  4. JCO Oncology Practice (3)
  5. JAMA Oncology (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Elsevier Inc. (6)
  3. Wiley Blackwell (6)
  4. American Medical Association (4)
  5. International Institute of Anticancer Research (1)
  6. JMIR Publications, Inc (1)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Ho, A. L.; Rao, S. S.; Shen, R.; Korte, S. H.; Lisa, D. M.; Ganly, I.; Katabi, N.; Patel, S. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Kelly, K.; Lipson, B.; Carlson, D.; Stambuk, H.; Haque, S.; Shen, R.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Sherman, E.; Haque, S.; Korte, S.; Lisa, D.; Shen, R.; Wu, N.; Pfister, D.
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Haque, S.; Stambuk, H.; Shen, R.; Carlson, D.; Pfister, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Baxi, S.; Shen, R.; Kelly, K. W.; Lipson, B. L.; Carlson, D.; Stambuk, H.; Haque, S.; Pfister, D. G.
    Anticancer Research (2011)

    Fulltext@MSK | Save
  • A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Pfister, D. G.; Haque, S.; Stambuk, H.; Lisa, D. M.; Shen, R.; Carlson, D.; Fury, M. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Acupuncture for pain and dysfunction after neck dissection: Results of a randomized controlled trial
    Journal Article

    Pfister, D. G.; Cassileth, B. R.; Deng, G. E.; Yeung, K. S.; Lee, J. S.; Garrity, D.; Cronin, A.; Lee, N.; Kraus, D.; Shaha, A. R.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (B) plus cisplatin (C) plus intensity-modulated radiation therapy (IMRT) for locoregionally advanced head and neck squamous cell cancer (HNSCC): Preliminary results
    Meeting Abstract

    Pfister, D. G.; Lee, N. Y.; Sherman, E.; Lisa, D.; Carlson, D.; Stambuk, H.; Shen, R.; Kraus, D.; Shah, J.; Fury, M. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of everolimus (E; RAD001) + low-dose weekly cisplatin (C) for patients with advanced solid tumors: Preliminary results
    Meeting Abstract

    Fury, M. G.; Sherman, E.; Stambuk, H.; Haque, S.; Lisa, D.; Shen, R.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save